Scopus BioPharma Inc (CE) (SCPS) Quotazione

Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (... Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (Duet), our majority-owned subsidiary. These programs include three distinctive complementary CpG-STAT3 inhibitors: Antisense ("DUET-101"); RNA silencing ("DUET-202"); and DNA-binding inhibitor ("DUET-301"). The Company may also seek to develop additional drug candidates and identify additional compelling technologies for potential acquisition, in-licensing and/or other similar transactions. Mostra di più